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Abstract
Background: Inappropriate marketing of human milk substitutes negatively influences efforts to protect breastfeeding. 
Although healthcare professionals can positively influence infant feeding decisions, government regulations permit manufac-
turers to communicate messages to them through advertising.
Research Aims: (1) To identify the extent of human milk substitute advertising in publications aimed at United Kingdom 
healthcare professionals and (2) to describe compliance with the International Code of Marketing of Breast- Milk Substitutes 
and United Kingdom Formula and Follow- on Formula Regulations.
Methods: This was a cross- sectional observational study. We reviewed publications targeting healthcare professionals working 
with families in the United Kingdom (N = 19). Quantity and type of human milk substitute advertisements, as a proportion of all 
advertising, in each publication were recorded. All unique advertisements were double assessed for compliance.
Results: Human milk substitute advertising was found in nine (47%) of the 19 publications (four affiliated with professional 
associations), making up 10.3% (n = 196) of these publications’ total advertising. Of human milk substitute advertisements 
found, 65.4% (n = 110) were for products used to manage cows’ milk protein allergy. Of the 32 unique human milk substitute 
advertisements found, none complied with the International Code of Marketing of Breast Milk Substitutes or United Kingdom 
Formula and Follow- on Formula Regulations.
Conclusions: Many healthcare professionals’ publications had non- compliant human milk substitute advertisements. There 
is an urgent need to ensure full compliance with international and local regulation in future advertisements and to consider 
whether advertisements are justified at all.
Keywords
bottle feeding, breastfeeding, breastfeeding barriers, breastfeeding knowledge, human milk substitute, infant formula, 
International Code of Marketing of Breast- Milk Substitutes, media analysis, public health
Background
The United Kingdom (UK) has some of the lowest breastfeed-
ing rates in the world, the reasons for which are complex and 
multifactorial. Evidence has shown that one important global 
barrier to breastfeeding is inappropriate marketing of human 
milk substitutes (HMS; McFadden et al., 2016). The marketing 
of HMS to healthcare professionals (HCP) who support families 
with infants contributes to a lack of awareness and understand-
ing about the physiological process of breastfeeding, increases 
social barriers by normalizing HMS use, and makes breastfeed-
ing an unattainable goal for many women (Grummer- Strawn & 
Stahlhofer, 2018; Rollins et al., 2016). While many midwives 
and health visitors in the UK receive training through the United 
Nations Children’s Fund (UNICEF) UK Baby Friendly Hospital 
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Initiative, some HCP receive limited pre- registration training 
about breastfeeding (Biggs et al., 2020; World Breastfeeding 
Trends Initiative, 2016).
The International Code of Marketing of Breast- Milk 
Substitutes (IC; World Health Organization [WHO], 1981) and 
the subsequent relevant World Health Assembly resolutions 
(WHO, 2018) provide recommendations for the marketing of 
HMS. The WHO (1981) has defined “breast- milk substitute” 
[HMS] as “any food being marketed or otherwise presented as a 
partial or total replacement for breast milk, whether or not suit-
able for that purpose” (p. 13). This definition therefore encom-
passes infant formula, follow- on formula, specialist formula 
(regulated as foods for special medical purposes [FSMP] in the 
European Union [EU]) and milks marketed for children over 1 
year of age (WHO, 2016). Wording in the IC clarifies that HCP 
are an important source of information and support for infant 
feeding practices and that they should be able to provide, if nec-
essary, unbiased information on the proper use and safe prepara-
tion of infant formula (WHO, 1981). The IC specifies that 
“information provided by manufacturers and distributors to 
health professionals regarding products within the scope of this 
Code should be restricted to “scientific and factual matters” 
(WHO, 1981, p. 12) and sets out requirements for countries to 
use in creating legislation. While almost all countries have signed 
up to the IC, few have fully adopted all the recommendations into 
law (WHO, 2020). EU regulations incorporate some provisions 
of the IC into law for all member states, which implement this in 
their domestic legislation. When the data were collected for this 
study, the UK legislation relating to composition, marketing and 
labelling of infant formula, follow- on formula and FSMP were 
Statutory Instruments acted in all four countries of the UK mir-
roring EU Directives 2006/141/EC and 1999/21/EC and any sub-
sequent amendments (The Infant Formula and Follow- on 
Formula [Wales] Regulations, 2007; The Infant Formula and 
Follow- on Formula [England] Regulations, 2007; The Infant 
Formula and Follow- on Formula [Scotland] Regulations, 2007; 
The Infant Formula and Follow- on Formula [Northern Ireland] 
Regulations, 2007; The Medical Food [England] Regulations, 
2000; The Medical Food [Wales] Regulations, 2000; The 
Medical Food [Northern Ireland] Regulations, 2000; Foods for 
Special Medical Purposes [Scotland] Regulations, 2000). The 
infant formula and follow- on formula legislation permits adver-
tising of infant formula in scientific and trade publications (where 
the audience is not the general public) and specifies that the 
advertisements only contain information of a “scientific and fac-
tual nature” UK of Health, 2013, p. 29). While this mirrors the 
wording in the IC, there is no mechanism in UK law to challenge 
or review any scientific and factual information provided by 
HMS manufacturers, making this wording inconsequential. 
Regulations for FSMP in the UK at the time we conducted this 
research had no restrictions related to product marketing. There 
is, however, specific wording in both the IC and UK legislation 
that can be used to assess advertisements’ compliance with the 
spirit of the IC and UK regulations, and this has been summa-
rized by Morgan et al. (2018).
Previously, advertising of HMS to HCP in the UK has 
been reviewed and the “scientific and factual” data presented 
in the advertisements challenged as being misleading or not 
in line with findings from independent policy makers, as well 
as containing emotive wording and imagery (Crawley & 
Westland, 2016; Westland & Crawley, 2019). The quantity 
and content of HMS advertisements in UK medical journals 
has also been reviewed. Although, only a small proportion of 
HMS advertising (1.7%) was found and IC compliance 
among reviewed publications containing HMS advertising 
was assessed as poor (Morgan et al., 2018). Concerns about 
the influence of HMS advertising have been highlighted by 
others (Costello et al., 2017; Morgan et al., 2019; Waterston 
& Wright, 2019) and this has contributed to some profes-
sional associations and publications reviewing and amend-
ing their policies on accepting advertising and funding from 
HMS companies (Godlee, 2019; Royal College of Paediatrics 
and Child Health, 2019). While some HCP may argue that 
they can easily distinguish between the sales pitch and the 
facts, no one is immune to the persuasive power of market-
ing (Hastings et al., 2020). Through this study we aimed (1) 
to identify the extent of human milk substitute advertising in 
publications aimed at UK HCP and (2) to describe compli-
ance with the IC and UK Regulations.
Methods
Design
This was a cross- sectional observational study. We chose this 
as the most appropriate design to determine the quantity of 
HMS advertisements found in HCP publications over a 
period of 1 year. The study protocol was approved by the 
Key Messages
• There is limited evidence on the quantity and con-
tent of advertisements for human milk substitutes 
in publications aimed at United Kingdom healthcare 
professionals.
• Human milk substitute advertisements were 
found in nine of the 19 (47%) publications 
searched, including four affiliated with professional 
associations.
• Of the 32 unique human milk substitute advertise-
ments found, none complied with the International 
Code of Marketing of Breast- Milk Substitutes or 
UK Formula and Follow- on Formula Regulations 
2007.
• Widespread, but non- compliant, human milk sub-
stitute advertisements in healthcare professional 
publications risk undermining efforts to protect 
and promote breastfeeding.
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ethics board at the London School of Hygiene and Tropical 
Medicine.
Setting and Relevant Context
Healthcare in the UK is free at point of use and provided univer-
sally, based on clinical need, by the National Health Service 
(NHS). The NHS is publicly funded through taxation in the UK 
and incorporates the four individual healthcare services of 
England, Wales, Scotland, and Northern Ireland. Pregnant 
women and new mothers in the UK are predominantly sup-
ported by midwives and health visitors, although additional sup-
port is provided by general practitioners (GPs), pediatricians, 
and nurses over the course of pregnancy and in the first 5 years 
of the child’s life. The majority of midwifery and health visiting 
services in the UK are either UNICEF Baby Friendly Hospital 
Initiative accredited or working towards accreditation. However, 
families may seek or be offered information and support from 
GPs, nurses, pediatricians, or dietitians, especially if there are 
complications or problems with infant feeding. The UK no lon-
ger routinely collects data on infant feeding, after the last UK 
Infant Feeding Survey conducted in 2010. Breastfeeding data 
are currently collected by each country individually at different 
timepoints and using different methods. NHS England reports 
breastfeeding initiation rates of 57% (NHS Digital, 2021), with 
48% of babies reported as receiving any human milk at their 
6–8- week appointments with a health visitor (Public Health 
England, 2021). Public Health Northern Ireland reports that 
49% of infants are receiving human milk on discharge from 
maternity services, reducing to 33% at 6 weeks (Public Health 
Intelligence Unit, 2019). Exclusive breastfeeding rates are 
recorded in Wales as 55% at birth, reducing to 25% at 6 weeks 
(Betsi Cadwaladr University Health Board, 2019). Scotland is 
the only UK country where an infant feeding survey is con-
ducted, and breastfeeding rates were 55% at 6 weeks (Healthier 
Scotland, 2017).
Sample
Journals and magazines available to UK- based midwives, health 
visitors, dietitians, pediatricians, GPs, and nurses through pro-
fessional associations, or privately published, between August 
2018 and July 2019 were reviewed. We chose these HCP groups 
because they have direct contact with pregnant women, infants, 
and young children and are therefore in a position to advise and 
potentially influence behavior through that advice. Publications 
targeting the HCP groups specified were selected for inclusion if 
they were automatically delivered as part of membership to an 
association, free magazines, and other well- known magazines 
or journals available for the specified HCP groups. At least two 
publications for each HCP area were selected, with at least one 
affiliated with a professional association. Publications contain-
ing no advertising material were excluded from the study.
For inclusion in the study, selected journals or magazines 
needed to be available as either hard copies or as full digital 
copies. To ensure consistency with the number of issues 
searched and the total number of issues published over a 
year, unavailable issues were replaced with the next avail-
able issue prior to the start of the data collection period. In 
total, 19 publications targeted for the six different HCP 
groups were included in the study, 10 of these were affiliated 
with professional associations. The number of issues of each 
publication varied, with the least number of issues from jour-
nals published quarterly (n = 4) and the most from those pub-
lished weekly (n = 46). In total, 207 issues of all publications 
were searched. As no statistical analysis of the data collected 
for this study was planned, we did not conduct a sample size 
calculation.
Measurement
Aim 1: Quantity and Type of HMS Advertising. To determine 
the quantity of advertising, an existing data collection tool 
created by Morgan et al. (2018) was adapted for the collec-
tion of the following information for each issue of the jour-
nals or magazines included in the study: number of pages 
(defined as one side of a physical page in the publication), 
number of pages given to advertisements, number and type of 
different advertisements, number and type of different HMS 
advertisements for infants under 6 months, number of differ-
ent advertisements for follow- on or toddler milk, number of 
pages given to HMS advertising for infants under 6 months, 
and number of pages given to advertising for follow- on or 
toddler milk. All printed content was included in the page 
count including front and back covers. All promotional mate-
rial was counted as advertising, including sponsored articles, 
information about courses, advertisements for events with 
clear sponsorship information, articles detailing award recip-
ients and events with clear sponsorship information, adver-
tisements for the publication or the professional association 
with which the publication was affiliated, and calls for sub-
missions. Fractions of pages of advertising were rounded to 
the nearest sixth of a page. Advertisements covering more 
than one page were counted as the same advertisement if for 
the same product and each page (one side of a physical page) 
was counted in the page count. Different advertisements for 
the same product were counted as separate advertisements if 
there was at least one clear page between them. Clearly des-
ignated recruitment or classified sections were not counted 
as advertising but were included in the page count. Articles 
sponsored by industry were counted as advertisements. For 
industry- sponsored articles covering several pages, all pages 
were counted in the page count of advertisements whether 
the sponsorship was clear on all pages or not.
Advertisements for all types of HMS were counted as 
HMS advertisements including infant formula, follow- on 
formula, toddler milks/growing up milks, specialist milks 
designated as FSMP for infants under 6 months, specialist 
milks designated as FSMP for infants 6 months and over, and 
advertorials for a specific brand of HMS. Sponsored articles 
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by HMS companies covering a topic but not advertising a 
specific product were not counted as HMS advertising but 
were counted as sponsored articles in the advertising count. 
HMS were categorized using information on brands and 
infant milk types marketed in the UK collated by First Steps 
Nutrition Trust ( www. firststepsnutrition. org). Each issue of 
each publication was primarily reviewed, and data recorded 
in the data collection tool using Microsoft Excel (2019). To 
ensure validity, each issue was then re- reviewed and recorded 
data were confirmed as accurate. In the event of any discrep-
ancies during the second review, a third review of the issue 
was undertaken.
Aim 2: Compliance of HMS Advertisements. All unique HMS 
advertisements found were assessed by two of the authors 
independently using the data collection tool created by 
Morgan et al. (2018). To determine compliance with the IC, 
HMS advertisements were assessed against measures relat-
ing to items specified in Article 7.2 (WHO, 1981; Table 1). 
Additional objective measures were added to the data col-
lection tool based on points from the Department of Health 
Guidance Notes on the Infant Formula and Follow- on 
Formula Regulations, 2007, covering information on adver-
tising to HCP (United Kingdom Department of Health, 
2013). These measures were used to assess HMS advertise-
ments for compliance with UK regulations. Any discrepan-
cies in the outcomes of specific advertisement assessments 
were discussed by the authors who conducted the assess-
ments in order to reach an agreement.
Data Collection
The selected publications covering the period of August 
2018–July 2019 were reviewed. Data about the quantity 
and type of HMS advertisements were collected by the lead 
author in July 2019 and, for hard copy publications, this 
took place at the Royal College of Midwives Library, the 
British Medical Association Library, and the British 
Library. For the two publications (Dietetics Today and 
Network Health Digest) available as full pdf digital copies, 
data were also collected in July 2019 by the lead author. 
Each issue of each publication covering the study period 
was hand searched and data were recorded in Microsoft 
Excel (2019). Photographs were taken of all unique HMS 
advertisements found during data collection and the first 
assessment of these was undertaken in July 2019 by the 
lead author, once data from all publications had been col-
lected. The second assessment of each unique HMS adver-
tisement found was conducted by a different author 
independently, during September and October 2020, using 
the photographs taken when data were originally collected 
and also recorded using the same data collection tool in 
Microsoft Excel (2019).
Data Analysis
The quantity and extent of HMS advertising (Aim 1) were 
analyzed using the number of pages of HMS advertising in 
comparison with the number of pages of all advertising to 
present the proportion of HMS advertising in each publica-
tion and across all publications. For compliance of HMS 
advertisements (Aim 2), each assessed HMS advertisement 
was categorized into the variables described in Table 1. The 
number of HMS advertisements meeting the criteria for each 
variable was compared with the total number of HMS adver-
tisements to calculate the proportion of HMS advertisements 
meeting the criteria for compliance with the IC and UK 
Regulations.
Results
Aim 1: Frequency and Type of HMS Advertisements
A total of 14,250 pages were searched and, across all publi-
cations, all advertising made up 18.4% (n = 2618.8 pages). 
However, among publications containing HMS advertising, 
the amount of all advertising was higher (20.9%, n = 1894 
pages). HMS advertisements were found in nine of the 19 
(47%) publications searched, making up 7.5% (n = 196) of 
all pages of advertising among all publications searched and 
10.3% (n = 196) among the nine containing HMS advertise-
ments. Of the 10 professional association affiliated publica-
tions, four (40%) contained HMS advertising. Dietitians, 
GPs, and pediatricians had professional membership associ-
ation affiliated magazines containing HMS advertising. 
Table 2 displays the amount of HMS advertising by publica-
tion. All issues (n = 26, 100%) of each of the three publica-
tions aimed at dietitians contained HMS advertisements, 
with two other publications (Journal of Health Visiting and 
Pulse) also containing HMS advertisements in the majority 
of issues (83%, n = 20). Figure 1 illustrates the proportion of 
HMS advertisements for each different HMS product type 
among all HMS advertisements found.
Aim 2: Compliance of Advertisements
None of the HMS advertisements were found to be compliant 
using the IC tool. No HMS advertisements were found to be 
compliant with UK Regulations using the adapted tool. Table 3 
provides the results of the assessment of HMS advertisements 
for compliance with the different variables specified to assess 
compliance with the IC and UK Regulations.
Discussion
While we know that inappropriate marketing by HMS com-
panies can result in devastating consequences for infant 
health in developing and emerging economies (Barennes 
et al., 2016; Kean et al., 2017; Save the Children UK, 2018), 
the health and wellbeing of UK infants also is undermined as 
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Table 1. Variable Definitions and Measurement.





as ‘scientific and 
factual’
WHO, 1981, Article 7.2, p. 12., 
United Kingdom Department 
of Health, 2013, Appendix IV, 
p. 29
Total n of statements
n of promotional statements







with IC Article 7.2
WHO, 1981, Article 7.2, p. 12 Contains statement(s) with wording expressing similarity /equivalence/
likeness to human milk or breastfeeding (yes/no)
List statement(s) with wording expressing similarity/equivalence/likeness 
to human milk or breastfeeding
Contains statement that HMS is superior to human milk or breastfeeding? 
(yes/no)
List statement(s) with wording expressing similarity/equivalence/likeness 
to human milk or breastfeeding
Different HMS 
advertisements 
with statement of 
superiority of human 
milk
To assess compliance 
with provision of 
‘Important Notice’
United Kingdom Department of 
Health, 2013
Paragraph 27, p11 & Paragraph 
57, p17
Is there a statement on the benefits and superiority of breastfeeding? (yes/
no)
Is 'Important Notice' included (concerning the superiority of breast 
feeding and advice on when infant formula should be used) (yes/no)
  If included, is the important notice afforded a high degree of prominence/ 
clearly visible? (yes/no)
Advertisements compliant 
with United Kingdom 
Infant Formula and 
Follow- on Formula 
Regulations 2007.
Assess compliance 
with all criteria 
specified in UK 
Regulations
United Kingdom Department of 
Health, 2013, Paragraph 47 
& 48, p. 15-16, Paragraph 27, 
p. 11
 
Compliant with UK Infant Formula and Follow- on Formula regulations 
2007? (yes/no)
• ‘Important Notice’ must be present
• Must answer ‘no’ to the following questions:
 { If the product advertised is follow- on or growing up milk, is it 
unclear from the text and images that the product advertised is for 
older babies? (yes/no)
 { Does the advertisement promote a range of products by making 
the brand the focus of the advertisement, rather than specific 
products? (yes/no)
 { Does the advertisement feature text or images which relate to 
pregnancy or the feeding or care of infants under 6 months? (yes/
no)
 { Does the advertisement include pictures or text that directly or 
indirectly relate or compare products to human milk? (yes/no)
 { Does the advertisement focus on carers emotions in relation to 
the feeding or care of infants under six months? (yes/no)
 { Does the advertisement feature babies that consumers may 
perceive as being under 6 months (even if they are over 6 months)? 
(yes/no)
 { Does the advertisement focus primarily on the promotion of 
ingredients, or the effect of ingredients, which are common to both 
follow- on formula and infant formula? (yes/no)
Advertisements compliant 
with the IC
To assess compliance 
with all criteria 
specified in IC
WHO, 1981, Article 4.2, p10 & 
Article 7.2, p. 12
Advertisement is compliant with IC (yes/no)
• Contains statement(s) with wording expressing similarity/equivalence/
likeness to human milk or breastfeeding (Yes/no) If yes to above, 
advertisement is not IC compliant
• Must answer ‘yes’ to the following:
 { Is there a statement on the benefits and superiority of 
breastfeeding? (yes/no)
 { Is there a statement on maternal nutrition and the preparation for 
and maintenance of breastfeeding? (yes/no)
 { Is there a statement on the negative effect on breastfeeding of 
introducing partial bottle- feeding? (yes/no)
 { Is there a statement on the difficulty of reversing the decision not 
to breastfeed? (yes/no)
 { Does material provide information about the use of infant BMS? 
(yes/no) If yes answer remaining questions. If no score through 
boxes.
 { Is there a statement on the proper use of infant BMS? (yes/no)
 { Is there a statement on the social and financial implications of the 
use of HMS? (yes/no)
 { Is there a statement on the health hazards of unnecessary or 
improper use of HMS? (yes/no)
Note. IC = International Code of Marketing Breast- Milk Substitutes; HMS = human milk substitutes; UK = United Kingdom.
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a result of HMS advertising. HCP have the opportunity to 
provide information and support to enable the initiation and 
continuation of breastfeeding. However, the combination of 
insufficient breastfeeding training and prevalence of HMS 
advertising in publications may influence the limited under-
standing of the physiology of breastfeeding for some HCP, 
leading to the provision of poor- quality information and sup-
port for breastfeeding (Biggs et al., 2020; Rothstein et al., 
2019). A sense of loyalty and inherent bias resulting from the 
acceptance of funding or advertising from HMS manufactur-
ers may further impact HCP ability to ensure the information 
they impart is evidence- based (Costello et al., 2017; 
Grummer- Strawn et al., 2019; van Tulleken, 2018; Waterston 
& Wright, 2019).
The high number of HMS advertisements for products 
marketed to manage cow’s milk allergies (CMA) illustrate 
issues raised in an investigation by van Tulleken (2018) into 
the provision of information on CMA from HMS companies. 
Marketing of products along with promotion of tools to iden-
tify CMA enabled a market for new products and strength-
ened relationships with HCP (van Tulleken, 2018). Similar 
to our findings, Morgan et al. (2018) also observed that HMS 
companies have heavily promoted these products to HCP 
and there was a concurrent increase in the diagnosis of CMA 
with prescription of these products increasing by nearly 
500% between 2006 and 2016 (van Tulleken, 2018).
Article 11.3 of the IC stipulates that manufacturers should 
consider themselves responsible for ensuring that their mar-
keting practices adhere to those laid out in the IC, indepen-
dent of other measures implemented in legislation (WHO, 
1981, p. 14). Yet, it appears from our findings, and those of 
others, that manufacturers are not fulfilling this obligation 
(Crawley & Westland, 2016; Morgan et al., 2018; Westland 
Table 2. Frequency of HMS Advertising in Selected Publications 
Grouped by Provider Type.
Type of Provider Publication
Pages
n (%)
Pediatricians Archives of Disease in 
Childhooda
7 (12)
Archives of Disease in 
Childhood Fetal & 
Neonatal Editiona
3 (25)
General Practitioners British Journal of General 
Practiceb
0 (0)
British Medical Journalc 32 (4.3)
Pulse 15 (5.5)
Dieticians Complete Nutrition 42 (18.6)
Dietetics Todayd 17 (12.9)
Network Health Digest 42 (33.6)
Health Visitors Community Practitionere 0 (0)
Journal of Health Visiting 26 (12.4)
Nurses General Practice Nursing 0 (0)
  Nursing Children & Young 
People f
0 (0)
  Nursing Standard f 0 (0)
  Nursing Times 0 (0)
  Primary Health Care f 0 (0)
Midwives British Journal of Midwifery 12 (9.8)
  Midwifery Digest 0 (0)
  Midwivesg 0 (0)
  Practising Midwifery 0 (0)
Note. Page is defined as one side of a physical page.
aPublications affiliated Royal College of Paediatrics and Child Health.
bPublication affiliated with Royal College of General Practitioners.
cPublication affiliated with British Medical Association.
dPublication affiliated with British Dietetic Association.
ePublication affiliated with Unite- Community Practitioner’s & Health 
Visitor’s Association.
fPublications affiliated with Royal College of Nursing.
gPublication affiliated with Royal College of Midwives.
Figure 1. Type of HMS Products Advertised as a Proportion of all 
HMS Advertisements.
Table 3. Assessment of Compliance Human Milk Substitutes 




Containing only promotional statements 6 (19)
Containing statement(s) expressing 
equivalence/similarity to human milk
13 (41)
Containing statement of superiority of human 
milk
20 (63)
Containing statement of superiority of human 
milk in ‘high degree of prominence’
6 (19)
Note. Compliance refers to compliance with the International Code 
of Marketing Breast- Milk Substitutes (WHO, 1981) and the United 
Kingdom Department of Health (2013). HMS = human milk substitutes.
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& Crawley, 2019). We do not know from our current work 
whether publications review the content of advertisements 
once space is purchased. Editors of publications which take 
advertising for revenue are unlikely to be able to influence 
the content of advertisements accepted; however, editorial 
boards can reflect on whether they want to support a journal 
that accepts HMS advertising and may be able to influence 
advertising policy. Even so, there are no mechanisms in the 
UK to establish the accuracy of any information given in 
HMS advertisements. Monitoring of advertisements to HCP 
in the UK is done by non- governmental organizations and 
when there has been breach of the guidance notes, which 
support regulation relating to this area (for example, if an 
advertisement does not provide a reference in a peer reviewed 
publication to support a statement), no action has been taken. 
Without robust procedures for monitoring and enforcement, 
UK legislation places HMS manufacturers in a trusted posi-
tion to regulate their own advertising content.
However, change is occurring. Three of the four publica-
tions affiliated with professional associations containing 
HMS advertising were published by The British Medical 
Journal Group, which announced in February 2019 that it 
would no longer be accepting advertisements from HMS 
companies (Godlee, 2019). The Royal College of Paediatrics 
and Child Health also made a statement in 2019 that it would 
no longer accept funding from HMS companies (Royal 
College of Paediatrics and Child Health, 2019). These 
announcements were made in the middle of our study period, 
explaining why we found HMS advertisements in The British 
Medical Journal, Archives of Disease in Childhood, and 
Archives of Disease in Childhood Fetal & Neonatal Edition. 
The British Dietetic Association is now the only professional 
association reported in this study whose publication contin-
ues to accept advertisements from HMS companies in 2021. 
Given that most dietitians receive limited pre- registration 
training about breastfeeding (World Breastfeeding Trends 
Initiative, 2016), it appears that they are at particular risk of 
exposure to advertising for products, which may undermine 
their support for breastfeeding.
New regulations specified by EU Directive 609/2013 
came into force in February 2020 through new delegated 
acts, with some changes to regulations relating to the market-
ing of infant formula, follow- on formula and foods intended 
for infants and young children, food for special medical pur-
poses, and total diet replacement for weight control (FSMP; 
Regulation 609/2013, 2013). There are now stronger regula-
tions related to how FSMP can be marketed, bringing them 
into line with infant formula. However, there is no difference 
in regulations for how products can be marketed to HCP; it 
is possible that these additional restrictions on marketing to 
the general public may prompt HMS companies to focus on 
advertising to HCP, using them to communicate messages to 
parents.
To the best of our knowledge, only one previous study, 
published in a non- peer review journal, has investigated the 
quantity and compliance of HMS advertisements in publica-
tions aimed at UK HCP and only medical journals were 
investigated (Morgan et al., 2018). We searched a wider 
range of publications available to a larger group of HCP with 
the potential to influence infant feeding decisions. 
Additionally, we searched all issues for each publication, 
rather than a sample of each, enabling us to ensure that our 
sample was representative and reducing the impact of issue- 
to- issue variations.
In order to add evidence to support the strengthening of 
regulation of HMS advertising, additional studies are needed 
to evaluate the content of HMS advertisements targeting 
HCP in order to determine compliance with the new February 
2020 UK regulations. Future researchers also should focus 
on the influence of HMS advertising on HCP knowledge and 
how this translates into practice. Additionally, given the 
increasing prevalence of online publications and resources, 
research is needed to investigate the prevalence of digital 
HMS advertising, which would help provide a more compre-
hensive picture of the way in which HCP are targeted by 
HMS companies.
Limitations
Data for this study were collected in 2019, reflecting the con-
tent of publications from 2018–2019 and may not be reflec-
tive of the current quantity and content of HMS 
advertisements. Although we have targeted key publications 
relevant to HCP working directly with families with infants, 
these may under- represent what HCP actually read, and other 
publications, which also may influence them, could have 
been omitted. We also focused on print media, which each 
HCP is likely to receive in hard copy but did not review 
e- versions of each publication or websites for either the pub-
lications or the affiliated professional associations—adver-
tising in these venues is likely to differ. We also cannot know 
whether advertisements identified directly influenced HCP 
subsequent infant feeding discussions or decisions.
Conclusion
If publications do carry HMS advertising, at the very least 
they should comply with the IC and UK Regulations. The 
actions of The British Medical Journal and The Royal 
College of Paediatrics and Child Health highlight the possi-
bility for professional associations to review and change pol-
icy, ensuring that they remain true to their core values to 
promote health, despite potential financial losses. As this 
study shows through the 10 publications that choose not to 
advertise any HMS, yet seem to be surviving and thriving, 
formula manufacturers’ money is not critical to publication 
success. What is critical is that infants have the best possible 
start in life. This involves optimal decisions about feeding. 
Advertisements are not and can never be an appropriate 
source of clinical information.
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